N@N

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2010 Financial Results Conference Call and Webcast

_{//health-fitness.news-articles.net/content/2010/ .. nancial-results-conference-call-and-webcast.html}
^{Published in Health and Fitness on Tuesday, October 12th 2010 at 6:15 GMT by Market Wire}  

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its third quarter 2010 financial results on Monday, October 25, 2010 after the financial markets close. The Company will host a conference call at 5:00 p.m. EDT.

The conference call will be webcast live and may be accessed from the aEvents & Presentationsa™ page of Vertexa™s website at [ www.vrtx.com ]. A replay of the conference call and webcast will be archived on the Companya™s website until November 8, 2010. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, epilepsy, cancer, and pain. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva^(R) is a registered trademark of the GlaxoSmithKline group of companies.

Vertexa™s press releases are available at [ www.vrtx.com ].

VRTX-WEB